ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)

$4.7 -0.04 (-0.8439%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) News Sources

Spotlight On Atea Pharmaceuticals And 2 Other Prominent Penny Stocks

25-05-2026

yahoo.com

Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026

27-05-2026

yahoo.com

Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?

09-06-2026

yahoo.com

Atea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should Know

18-06-2026

yahoo.com

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

25-06-2026

yahoo.com

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

14-07-2026

yahoo.com

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

28-07-2026

yahoo.com

Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial

28-07-2026

yahoo.com

Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial

29-07-2026

yahoo.com

FDA reviewers criticize Replimune drug; ProMIS climbs on Alzheimer’s data

29-07-2026

biopharmadive.com

ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) Sentiment Trend

0 25 50 75 100 94 81 67 93 83 89 81 87 89 2 25-05-2026 27-05-2026 09-06-2026 18-06-2026 25-06-2026 14-07-2026 28-07-2026 29-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) FAQs

toggle

What is the current price of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?

The current price of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is $4.7.


toggle

ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) absolute price change since previous trading day?

The absolute price change of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) since the previous trading day is $-0.04.


toggle

ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) percentage price change since previous trading day?

The percentage price change of ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) since the previous trading day is -0.8439%.


toggle

What is the most recent average sentiment score for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?

The most recent average sentiment score for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is 77 out of 100.


toggle

What is the most recent average sentiment for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)?

The most recent sentiment for ATEA PHARMACEUTICALS INC (AVIR:NASDAQ) is .


SEC-8K** Filing Available For ATEA PHARMACEUTICALS INC (AVIR:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.